See related guidelines by the Canadian Task Force on Preventive Health Care on page
1991 and at www. cmaj. ca/lookup/doi/10.1503/cmaj. 110334 larger decline seen among …

We analysed the relation between tumour sizes and stages and the reported effects on
breast cancer mortality with and without screening in trials and observational studies. The …

The consensus that breast screening is effective for women aged 50-59 years was shattered
when Gotzsche and Olsen suggested that there are no reliable data to support screening by …

Breast cancer is still a major public health issue worldwide; according to present estimates,
1 million women will be diagnosed with breast cancer this year. There are no longer any …

Many countries provide mammographic screening for breast cancer as part of regional or
national public health policy, and some programmes have been in place for several years …

The new england journal of medicine n engl j med nejm. org e31 (2) sis that was made
when the woman was in her 40s, and breast cancer is a leading cause of premature death …

The American Cancer Society, the American College of Radiologists, and the American
College of Obstetricians and Gynecologists are among the handful of organizations in the …

Arguments over the credibility of the randomized screening mammography trials are red
herrings. The overall results of the trials suggest that screening very likely reduces breast …

Before being widely implemented, mammography screening was tested in randomised
controlled trials in the 1960s to 80s. Meta-analyses of these trials showed a relative …

Since the late 1980s, there has been broad agreement, with invitation to screening in
women aged 40–49 years and a significant 27% reduction in women aged 50–74 with few …